3/6
10:37 pm
evh
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage [Yahoo! Finance]
Neutral
Report
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage [Yahoo! Finance]
3/2
11:04 am
evh
Evolent Health (EVH) had its "buy" rating reaffirmed by TD Cowen.
Medium
Report
Evolent Health (EVH) had its "buy" rating reaffirmed by TD Cowen.
3/2
10:34 am
evh
Evolent Health (EVH) had its price target lowered by Oppenheimer Holdings, Inc. from $12.00 to $6.00. They now have an "outperform" rating on the stock.
Medium
Report
Evolent Health (EVH) had its price target lowered by Oppenheimer Holdings, Inc. from $12.00 to $6.00. They now have an "outperform" rating on the stock.
2/27
07:05 pm
evh
Evolent Health and iRhythm Shares Are Falling, What You Need To Know [Yahoo! Finance]
Medium
Report
Evolent Health and iRhythm Shares Are Falling, What You Need To Know [Yahoo! Finance]
2/26
05:00 pm
evh
Evolent to Participate in Upcoming Investor Conferences
Low
Report
Evolent to Participate in Upcoming Investor Conferences
2/26
03:41 pm
evh
Evolent Health (EVH) had its price target lowered by Citigroup Inc. from $6.00 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (EVH) had its price target lowered by Citigroup Inc. from $6.00 to $4.00. They now have a "buy" rating on the stock.
2/26
02:28 pm
evh
Evolent Health (EVH) had its price target lowered by UBS Group AG from $10.00 to $5.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (EVH) had its price target lowered by UBS Group AG from $10.00 to $5.00. They now have a "buy" rating on the stock.
2/25
04:21 pm
evh
Evolent Health (EVH) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Medium
Report
Evolent Health (EVH) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
2/25
03:07 pm
evh
Evolent Health (EVH) was given a new $6.00 price target by Truist Financial Corporation.
Low
Report
Evolent Health (EVH) was given a new $6.00 price target by Truist Financial Corporation.
2/25
11:54 am
evh
Evolent Health (EVH) had its price target lowered by Needham & Company LLC from $15.00 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health (EVH) had its price target lowered by Needham & Company LLC from $15.00 to $4.00. They now have a "buy" rating on the stock.
2/25
10:24 am
evh
Evolent Health (EVH) had its price target lowered by Royal Bank Of Canada from $5.00 to $3.00. They now have a "sector perform" rating on the stock.
Low
Report
Evolent Health (EVH) had its price target lowered by Royal Bank Of Canada from $5.00 to $3.00. They now have a "sector perform" rating on the stock.
2/25
10:07 am
evh
Evolent Health (EVH) had its "outperform" rating reaffirmed by BMO Capital Markets.
Low
Report
Evolent Health (EVH) had its "outperform" rating reaffirmed by BMO Capital Markets.
2/25
08:03 am
evh
Evolent Health (EVH) had its price target lowered by BTIG Research from $10.00 to $8.00. They now have a "buy" rating on the stock.
High
Report
Evolent Health (EVH) had its price target lowered by BTIG Research from $10.00 to $8.00. They now have a "buy" rating on the stock.
2/25
08:00 am
evh
Evolent Health (EVH) was downgraded by KeyCorp from "overweight" to "sector weight".
High
Report
Evolent Health (EVH) was downgraded by KeyCorp from "overweight" to "sector weight".
2/25
12:27 am
evh
Evolent Health Inc (EVH) Q4 2025 Earnings Call Highlights: Strong Oncology Growth and Strategic ... [Yahoo! Finance]
High
Report
Evolent Health Inc (EVH) Q4 2025 Earnings Call Highlights: Strong Oncology Growth and Strategic ... [Yahoo! Finance]
2/24
04:59 pm
evh
Evolent Health: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Evolent Health: Q4 Earnings Snapshot [Yahoo! Finance]
2/24
04:55 pm
evh
Evolent Health (NYSE:EVH) Reports Q4 CY2025 In Line With Expectations [Yahoo! Finance]
High
Report
Evolent Health (NYSE:EVH) Reports Q4 CY2025 In Line With Expectations [Yahoo! Finance]
2/24
04:10 pm
evh
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
High
Report
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
2/22
10:22 pm
evh
Evolent Health (EVH) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Evolent Health (EVH) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/9
09:42 am
evh
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion [Yahoo! Finance]
Low
Report
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion [Yahoo! Finance]
2/4
11:02 am
evh
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
Low
Report
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
2/2
01:46 pm
evh
MedeAnalytics Appoints Chris Lance as Chief Product Officer [Yahoo! Finance]
Low
Report
MedeAnalytics Appoints Chris Lance as Chief Product Officer [Yahoo! Finance]
2/2
08:04 am
evh
Evolent Health (NYSE:EVH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock, down previously from $16.00.
Low
Report
Evolent Health (NYSE:EVH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock, down previously from $16.00.
1/9
10:58 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.
1/6
08:02 am
evh
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $11.00 to $10.00. They now have a "market outperform" rating on the stock.
Low
Report
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $11.00 to $10.00. They now have a "market outperform" rating on the stock.